These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 39417278)
1. Myocardial Disarray and Fibrosis across Hypertrophic Cardiomyopathy Stages Associate with ECG Markers of Arrhythmic Risk. Ashkir Z; Samat AHA; Ariga R; Finnigan L; Jermy S; Akhtar MA; Sarto G; Murthy P; Wong B; Cassar MB; Beyhoff N; Wicks EW; Thomson K; Mahmod M; Tunnicliffe L; Neubauer S; Watkins H; Raman B Eur Heart J Cardiovasc Imaging; 2024 Oct; ():. PubMed ID: 39417278 [TBL] [Abstract][Full Text] [Related]
2. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias. Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142 [TBL] [Abstract][Full Text] [Related]
3. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy. Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608 [TBL] [Abstract][Full Text] [Related]
4. Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography. Joy G; Lopes LR; Webber M; Ardissino AM; Wilson J; Chan F; Pierce I; Hughes RK; Moschonas K; Shiwani H; Jamieson R; Velazquez PP; Vijayakumar R; Dall'Armellina E; Macfarlane PW; Manisty C; Kellman P; Davies RH; Tome M; Koncar V; Tao X; Guger C; Rudy Y; Hughes AD; Lambiase PD; Moon JC; Orini M; Captur G J Am Coll Cardiol; 2024 Mar; 83(11):1042-1055. PubMed ID: 38385929 [TBL] [Abstract][Full Text] [Related]
5. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607 [TBL] [Abstract][Full Text] [Related]
6. Diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy: a comparison of motion-compensated spin echo and stimulated echo techniques. Khalique Z; Scott AD; Ferreira PF; Nielles-Vallespin S; Firmin DN; Pennell DJ MAGMA; 2020 Jun; 33(3):331-342. PubMed ID: 31758419 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy. Tondi L; Disabato G; D'Andria P; Attanasio A; Guida G; Pieruzzi F; De Angeli G; Canepa M; Carrafiello G; Piepoli M; Spagnolo P; Lombardi M; Camporeale A Front Cardiovasc Med; 2024; 11():1458705. PubMed ID: 39411176 [TBL] [Abstract][Full Text] [Related]
8. "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy". Tondi L; Pica S; Crimi G; Disabato G; Figliozzi S; Camporeale A; Bernardini A; Tassetti L; Milani V; Piepoli MF; Lombardi M Int J Cardiol; 2024 Aug; 408():132135. PubMed ID: 38705206 [TBL] [Abstract][Full Text] [Related]
9. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy. Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients. Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005 [TBL] [Abstract][Full Text] [Related]
11. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes. Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365 [TBL] [Abstract][Full Text] [Related]
13. Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations. Jalanko M; Heliö T; Mustonen P; Kokkonen J; Huhtala H; Laine M; Jääskeläinen P; Tarkiainen M; Lauerma K; Sipola P; Laakso M; Kuusisto J; Nikus K J Electrocardiol; 2018; 51(6):983-989. PubMed ID: 30497761 [TBL] [Abstract][Full Text] [Related]
14. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy. Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754 [TBL] [Abstract][Full Text] [Related]
15. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy. Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning. Captur G; Heywood WE; Coats C; Rosmini S; Patel V; Lopes LR; Collis R; Patel N; Syrris P; Bassett P; O'Brien B; Moon JC; Elliott PM; Mills K Mol Cell Proteomics; 2020 Jan; 19(1):114-127. PubMed ID: 31243064 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy. Meucci MC; Lillo R; Lombardo A; Lanza GA; Bootsma M; Butcher SC; Massetti M; Manna R; Bax JJ; Crea F; Ajmone Marsan N; Graziani F Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):542-551. PubMed ID: 35900225 [TBL] [Abstract][Full Text] [Related]
18. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy. Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928 [TBL] [Abstract][Full Text] [Related]
19. Micro-computed tomography (micro-CT) for the assessment of myocardial disarray, fibrosis and ventricular mass in a feline model of hypertrophic cardiomyopathy. Novo Matos J; Garcia-Canadilla P; Simcock IC; Hutchinson JC; Dobromylskyj M; Guy A; Arthurs OJ; Cook AC; Luis Fuentes V Sci Rep; 2020 Nov; 10(1):20169. PubMed ID: 33214588 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy. Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]